Skip to main content

Eden Research to use Polish approval for Mevalone as springboard into central Europe

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Eden Research PLC (AIM:EDEN, OTCQB:EDNSF) CEO Sean Smith speaks to Proactive after announcing that the company's flagship bio-fungicide Mevalone has been approved for use by Polish regulators.

Smith says that the authorisation in Poland is just the beginning of a cascading process that will continue into adjacent European Union member states as well as the United Kingdom.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  255.33
-3.25 (-1.26%)
AAPL  345.60
+4.33 (1.27%)
AMD  581.48
-24.05 (-3.97%)
BAC  49.95
-4.02 (-7.44%)
GOOG  349.79
+0.27 (0.08%)
META  743.36
-19.14 (-2.51%)
MSFT  538.63
-4.82 (-0.89%)
NVDA  223.55
-4.97 (-2.17%)
ORCL  133.61
-9.59 (-6.70%)
TSLA  367.68
-7.56 (-2.01%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.